Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Change in attitude may ease chronic pain by aiding sleep: Study

Change in attitude may ease chronic pain by aiding sleep: Study

FDA extends review period for linaclotide NDA to treat constipation

FDA extends review period for linaclotide NDA to treat constipation

Women with IBS more likely to suffer from ectopic pregnancies, miscarriages

Women with IBS more likely to suffer from ectopic pregnancies, miscarriages

Hypnotherapy effective for treating bowel disorder IBS

Hypnotherapy effective for treating bowel disorder IBS

Patients with IBD, other GI disorders may be exposed to higher levels of diagnostic radiation

Patients with IBD, other GI disorders may be exposed to higher levels of diagnostic radiation

Patients with IBS have higher prevalence of early adverse life events

Patients with IBS have higher prevalence of early adverse life events

Rifaximin and lubiprostone offer best options for patients with IBS

Rifaximin and lubiprostone offer best options for patients with IBS

GUCY2C gene mutation leads to familial diarrhea syndrome

GUCY2C gene mutation leads to familial diarrhea syndrome

Lexicon receives FDA Orphan Drug designation for telotristat etiprate to treat carcinoid syndrome

Lexicon receives FDA Orphan Drug designation for telotristat etiprate to treat carcinoid syndrome

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

Ovarian cancer – push for greater awareness

Ovarian cancer – push for greater awareness

SK Biopharmaceuticals' YKP3089 receives Korea Drug Development Fund

SK Biopharmaceuticals' YKP3089 receives Korea Drug Development Fund

Positive results from AltheRx Solabegron Phase II study on overactive bladder

Positive results from AltheRx Solabegron Phase II study on overactive bladder

Gluten-free diet more of a fad than absolute necessity for many

Gluten-free diet more of a fad than absolute necessity for many

Pharmos reports net loss of $0.4 million for fourth quarter 2011

Pharmos reports net loss of $0.4 million for fourth quarter 2011

Ironwood prices public offering of 5,250,000 shares of common stock

Ironwood prices public offering of 5,250,000 shares of common stock

Study implicates 'arms race' between genes and germs

Study implicates 'arms race' between genes and germs

Clear link between marijuana use in young males and cyclic vomiting syndrome

Clear link between marijuana use in young males and cyclic vomiting syndrome

Stimflora launches new dietary health product

Stimflora launches new dietary health product

Bionomics, Ironwood partner to develop and commercialize novel anti-anxiety compound

Bionomics, Ironwood partner to develop and commercialize novel anti-anxiety compound

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.